Matthieu S.

Matthieu S. is a scientist specializing in synthetic chemistry with extensive experience in medicinal chemistry and organic synthesis. Currently at NovAliX since June 2022, Matthieu S. focuses on synthesizing small organic molecules for pharmaceutical clients, involving retrosynthesis, purification, and characterization techniques such as LCMS and NMR, while also mentoring research assistants and presenting results. Matthieu S. completed a PhD in Medicinal Chemistry at Monash University, where the research centered on developing small organic molecules to inhibit calcium channels for pain management. Prior experiences include research internships at CSIRO, Università degli Studi di Firenze, and a quality control technician internship at Merck Millipore. Educational qualifications include a Doctor of Philosophy from Monash University, a Diplôme d'ingénieur in General Chemistry from Chimie ParisTech - PSL, a Master of Science in Medicinal Chemistry & Molecular Pharmacology from Université Paris Cité, and studies in CPGE Physique-Chimie at Lycée Jeanne d'Albret.